Barclays’s Immutep IMMP Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMP
XT
HSA
Barclays's IMMP Position: Q2 2026 in Review
Barclays increased its Immutep (IMMP) stake by 52% in Q2 2026, buying an estimated $58 and bringing the position to 391 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #5138.
Barclays first reported a position in IMMP in Q2 2021 and has held it in 7 quarters since. The position peaked at $1K in Q3 2021. 25 funds tracked by Wall St. Rank hold IMMP as of Q2 2026.
- Barclays held 391 shares of Immutep worth $163 as of Q2 2026.
- Barclays bought 133 Immutep shares in Q2 2026, an estimated $58.
- Immutep made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5138 holding.
- Barclays first reported a position in Immutep in Q2 2021 and has held it in 7 quarters since.
- Barclays's Immutep position peaked at $1K in Q3 2021.
- 25 funds tracked by Wall St. Rank held Immutep as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.